Pfizer Inc. (PFE) Q4 2021 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q4 2021 earnings call dated Feb. 08, 2022 Corporate Participants: Chris Stevo — Senior Vice President and Chief...
Pfizer Inc. (NYSE: PFE) Q4 2021 earnings call dated Feb. 08, 2022 Corporate Participants: Chris Stevo — Senior Vice President and Chief...
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from...
The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q4 2021 earnings call dated Feb. 04, 2022 Corporate Participants: Mark HudsonĀ —Ā Director, Investor Relations Leonard...
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion,...
Merck & Co., Inc. (NYSE: MRK) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Peter Dannenbaum — Vice President of...
Cigna Corporation (NYSE: CI) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Ralph GiacobbeĀ —Ā Investor Relations David CordaniĀ —Ā Chairman and...
Eli Lilly and Company (NYSE: LLY) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Hern ā Investor Relations David...
Biogen, Inc. (NASDAQ: BIIB) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Michael HenckeĀ —Ā Head of Investor Relations Michel...
Cardinal Health, Inc. (NYSE: CAH) Q2 2022 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin MoranĀ —Ā Vice President of Investor...
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The...
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today. Total revenue decreased 4% year-over-year to $2.73 billion. GAAP...
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year....
Humana IncĀ (NYSE: HUM) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lisa StonerĀ —Ā Vice President of Investor Relations...
AbbVieĀ (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth SheaĀ —Ā Vice President, Investor Relations Richard A....
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler — Vice President, Investor Relations...
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4%...
The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene...
Dr. Reddy’s Laboratories (NSE: DRREDDY) Q3 2022 earnings call dated Jan. 28, 2022 Corporate Participants: Amit AgarwalĀ —Ā Head of Investor Relations...
Vertex Pharmaceuticals IncorporatedĀ (NASDAQ: VRTX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Michael PartridgeĀ —Ā Senior Vice President of...
Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human biology...